BioSpace News Archive

Press Releases

Cue Biopharma Announces Strategic Transition in Leadership to Further Enable Next Stage of Growth with Disruptive Autoimmune Therapeutic Candidates

September 30, 2025
·
8 min read
Press Releases

Children’s Hospital of Philadelphia Pediatric Cancer Researcher Receives Prestigious Grant for Advancing Rare Tumor Studies

September 30, 2025
·
4 min read
Press Releases

Connect Biopharma Presents Data Supporting Rademikibart at the European Respiratory Society Congress 2025

September 30, 2025
·
9 min read
Press Releases

Revolution Medicines Announces Key Leadership Additions, including Alan Sandler, M.D. as Chief Development Officer

September 30, 2025
·
5 min read
Press Releases

Revagenix, Inc. Announces Changes to Its Board of Directors

September 30, 2025
·
2 min read
Press Releases

Oncolytics Biotech® Announces Update for Potential First-Line Pancreatic Cancer Registration Study

September 30, 2025
·
4 min read
Press Releases

Modular Medical Announces Exercise of Warrants for $4.4 Million in Gross Proceeds

September 30, 2025
·
4 min read
Press Releases

Artelo Biosciences Announces Presentation of Positive Interim Phase 2 CAReS Data on ART27.13 at the 2025 Cancer Cachexia Society Conference

September 30, 2025
·
7 min read
Press Releases

Dyne Therapeutics Receives Orphan Drug Designation in Japan for DYNE-251 in Duchenne Muscular Dystrophy

September 30, 2025
·
7 min read
Press Releases

CorMedix Announces Completion of Enrollment in Phase III ReSPECT Clinical Trial for REZZAYO

September 30, 2025
·
6 min read